Brainsway (BRSYF) Other Gross PP&E Adjustments (2025 - 2026)

Brainsway posted quarterly Other Gross PP&E Adjustments of -$6.2 million for Q1 2026, up 1.93% on a QoQ basis from -$6.3 million in Q4 2025.

Brainsway (BRSYF) has 2 years of Other Gross PP&E Adjustments data on file, last reported at -$6.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Gross PP&E Adjustments changed N/A year-over-year to -$6.2 million; the trailing twelve-month figure through Mar 2026 stood at -$6.2 million (changed N/A YoY), and the FY2025 full-year result was -$6.3 million, changed N/A from the prior year.
  • Other Gross PP&E Adjustments for Q1 2026 stood at -$6.2 million, up from -$6.3 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at -$6.2 million in Q1 2026 and bottomed at -$6.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 23.14 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -405.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -547.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -99.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.55 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.39 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 991.00 Mn
10 Brainsway - - 11.68 Mn -6.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6.21 Mn
Mar 31, 2026 -6.21 Mn
Dec 31, 2025 -6.34 Mn
Dec 31, 2025 -6.34 Mn